Industry News
Biotechnology Industry News
Improving CAR-T cell therapy with more sensitive tumor identification
Improving CAR-T cell therapy with more sensitive tumor identification aliu Wed, 08/25/2021 - 06:14
Brii’s COVID-19 antibody slashes hospitalizations and deaths in late-phase trial, teeing it up to take on Regeneron
Brii's COVID-19 antibody slashes hospitalizations and deaths in late-phase trial, teeing it up to take on Regeneron ntaylor Wed, 08/25/2021 - 05:55
Atavistik Bio secures $60M series A to tackle metabolic diseases, cancers with former Peloton, Blueprint Medicines execs at the helm
Atavistik Bio secures $60M series A to tackle metabolic diseases, cancers with former Peloton, Blueprint Medicines execs at the helm klahucik Tue, 08/24/2021 - 17:24
Pfizer deal a spark for M&A, or just fuel for an empty pipeline? Analysts try to read the tea leaves
Pfizer deal a spark for M&A, or just fuel for an empty pipeline? Analysts try to read the tea leaves badams Tue, 08/24/2021 - 09:33
The link between COVID-19, rattlesnake venom and a killer enzyme inspires treatment target
The link between COVID-19, rattlesnake venom and a killer enzyme inspires treatment target arlene.weintraub Tue, 08/24/2021 - 09:03
The FDA wants more data. Stealth is filing for approval anyway
The FDA wants more data. Stealth is filing for approval anyway ntaylor Tue, 08/24/2021 - 08:36
BlueWillow shares early look at data on nasal anthrax vaccine
BlueWillow shares early look at data on nasal anthrax vaccine ntaylor Tue, 08/24/2021 - 08:29
Anti-aging foundation SENS fires de Grey after allegations he interfered with investigation into his conduct
Anti-aging foundation SENS fires de Grey after allegations he interfered with investigation into his conduct aarmstrong Mon, 08/23/2021 - 09:40
Axsome sees depression drug decision delayed as FDA kicks expected CRL can down the road
Axsome sees depression drug decision delayed as FDA kicks expected CRL can down the road badams Mon, 08/23/2021 - 09:29
CRISPR pinpoints new leukemia target and a ‘pocket’ that could make it druggable
CRISPR pinpoints new leukemia target and a 'pocket' that could make it druggable arlene.weintraub Mon, 08/23/2021 - 09:08
Pfizer swallows CD47 biotech Trillium in $2.3B takeover
Pfizer swallows CD47 biotech Trillium in $2.3B takeover ntaylor Mon, 08/23/2021 - 08:26
Genevant pens $303M biobucks pact with Takeda, aiming at rare liver diseases using gene therapy
Genevant pens $303M biobucks pact with Takeda, aiming at rare liver diseases using gene therapy badams Mon, 08/23/2021 - 07:32
Sabatini, biotech founder and mTOR pioneer, ousted after sexual harassment investigation
Sabatini, biotech founder and mTOR pioneer, ousted after sexual harassment investigation ntaylor Mon, 08/23/2021 - 06:17
Tyra Biosciences wants to bank $100M for an IPO
Tyra Biosciences wants to bank $100M for an IPO badams Mon, 08/23/2021 - 04:14
MGH team shows how injured muscles might be repaired with patients’ own skin cells
MGH team shows how injured muscles might be repaired with patients' own skin cells arlene.weintraub Fri, 08/20/2021 - 09:01
After Aduhelm fallout, FDA veteran Woodcock out of running for commish job: report
After Aduhelm fallout, FDA veteran Woodcock out of running for commish job: report badams Fri, 08/20/2021 - 08:32
AstraZeneca antibody cocktail slashes risk of symptomatic COVID-19, setting up regulatory filings and a lifeline for the immunosuppressed
AstraZeneca antibody cocktail slashes risk of symptomatic COVID-19, setting up regulatory filings and a lifeline for the immunosuppressed ntaylor Fri, 08/20/2021 - 05:00
China’s Abogen raises $700M series C for mRNA trials, catapulting itself into the big leagues
China's Abogen raises $700M series C for mRNA trials, catapulting itself into the big leagues ntaylor Fri, 08/20/2021 - 04:07
Despite upbeat tones from analysts, Fate Therapeutics’ stock drops on blood cancer readout
Despite upbeat tones from analysts, Fate Therapeutics' stock drops on blood cancer readout badams Fri, 08/20/2021 - 04:00
After Bristol Myers buyout, MyoKardia’s clinical ops lead jumps ship to Esker Therapeutics
After Bristol Myers buyout, MyoKardia's clinical ops lead jumps ship to Esker Therapeutics badams Thu, 08/19/2021 - 09:39